Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction

(<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol is an important pharmaceutical intermediate of a chemokine CCR5 antagonist. In the present study, a bioprocess for the asymmetric reduction of 4-(trifluoromethyl)acetophenone to (<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol wa...

Full description

Bibliographic Details
Main Authors: Ying Chen, Nana Xia, Yuewang Liu, Pu Wang
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Catalysts
Subjects:
Online Access:https://www.mdpi.com/2073-4344/9/4/391
id doaj-49535d7d0a224ab09ee600ce66feca4c
record_format Article
spelling doaj-49535d7d0a224ab09ee600ce66feca4c2020-11-25T02:01:07ZengMDPI AGCatalysts2073-43442019-04-019439110.3390/catal9040391catal9040391Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated ReductionYing Chen0Nana Xia1Yuewang Liu2Pu Wang3College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, ChinaCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, China(<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol is an important pharmaceutical intermediate of a chemokine CCR5 antagonist. In the present study, a bioprocess for the asymmetric reduction of 4-(trifluoromethyl)acetophenone to (<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol was developed by recombinant <i>Escherichia coli</i> cells with excellent enantioselectivity. In order to overcome the conversion limitation performed in the conventional buffer medium resulting from poor solubility of non-natural substrate, we subsequently established a polar organic solvent-aqueous medium to improve the efficacy. Isopropanol was selected as the most suitable cosolvent candidate, based on the investigation on a substrate solubility test and cell membrane permeability assay in different organic solvent-buffer media. Under the optimum conditions, the preparative-scale asymmetric reduction generated a 99.1% yield with &gt;99.9% product enantiomeric excess (ee) in a 15% (<i>v</i>/<i>v</i>) isopropanol proportion, at 100 mM of 4-(trifluoromethyl)acetophenone within 3 h. Compared to bioconversion in the buffer medium, the developed isopropanol-aqueous system enhanced the substrate concentration by 2-fold with a remarkably improved yield (from 62.5% to 99.1%), and shortened the reaction time by 21 h. Our study gave the first example for a highly enantioselective production of (<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol by a biological method, and the bioreduction of 4-(trifluoromethyl)acetophenone in a polar organic solvent-aqueous system was more efficient than that in the buffer solution only. This process is also scalable and has potential in application.https://www.mdpi.com/2073-4344/9/4/391(<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanolasymmetric bioreductionrecombinant whole-cell catalysispolar organic solvent-aqueous system
collection DOAJ
language English
format Article
sources DOAJ
author Ying Chen
Nana Xia
Yuewang Liu
Pu Wang
spellingShingle Ying Chen
Nana Xia
Yuewang Liu
Pu Wang
Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction
Catalysts
(<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol
asymmetric bioreduction
recombinant whole-cell catalysis
polar organic solvent-aqueous system
author_facet Ying Chen
Nana Xia
Yuewang Liu
Pu Wang
author_sort Ying Chen
title Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction
title_short Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction
title_full Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction
title_fullStr Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction
title_full_unstemmed Efficient Biocatalytic Preparation of Optically Pure (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol by Recombinant Whole-Cell-Mediated Reduction
title_sort efficient biocatalytic preparation of optically pure (<i>r</i>)-1-[4-(trifluoromethyl)phenyl]ethanol by recombinant whole-cell-mediated reduction
publisher MDPI AG
series Catalysts
issn 2073-4344
publishDate 2019-04-01
description (<i>R</i>)-1-[4-(Trifluoromethyl)phenyl]ethanol is an important pharmaceutical intermediate of a chemokine CCR5 antagonist. In the present study, a bioprocess for the asymmetric reduction of 4-(trifluoromethyl)acetophenone to (<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol was developed by recombinant <i>Escherichia coli</i> cells with excellent enantioselectivity. In order to overcome the conversion limitation performed in the conventional buffer medium resulting from poor solubility of non-natural substrate, we subsequently established a polar organic solvent-aqueous medium to improve the efficacy. Isopropanol was selected as the most suitable cosolvent candidate, based on the investigation on a substrate solubility test and cell membrane permeability assay in different organic solvent-buffer media. Under the optimum conditions, the preparative-scale asymmetric reduction generated a 99.1% yield with &gt;99.9% product enantiomeric excess (ee) in a 15% (<i>v</i>/<i>v</i>) isopropanol proportion, at 100 mM of 4-(trifluoromethyl)acetophenone within 3 h. Compared to bioconversion in the buffer medium, the developed isopropanol-aqueous system enhanced the substrate concentration by 2-fold with a remarkably improved yield (from 62.5% to 99.1%), and shortened the reaction time by 21 h. Our study gave the first example for a highly enantioselective production of (<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol by a biological method, and the bioreduction of 4-(trifluoromethyl)acetophenone in a polar organic solvent-aqueous system was more efficient than that in the buffer solution only. This process is also scalable and has potential in application.
topic (<i>R</i>)-1-[4-(trifluoromethyl)phenyl]ethanol
asymmetric bioreduction
recombinant whole-cell catalysis
polar organic solvent-aqueous system
url https://www.mdpi.com/2073-4344/9/4/391
work_keys_str_mv AT yingchen efficientbiocatalyticpreparationofopticallypureiri14trifluoromethylphenylethanolbyrecombinantwholecellmediatedreduction
AT nanaxia efficientbiocatalyticpreparationofopticallypureiri14trifluoromethylphenylethanolbyrecombinantwholecellmediatedreduction
AT yuewangliu efficientbiocatalyticpreparationofopticallypureiri14trifluoromethylphenylethanolbyrecombinantwholecellmediatedreduction
AT puwang efficientbiocatalyticpreparationofopticallypureiri14trifluoromethylphenylethanolbyrecombinantwholecellmediatedreduction
_version_ 1724958675576029184